To ascertain the effects of selective impairment of the fixed macrophage compartment on host defense, rabbit anti-rat Kupffer cell serum was raised and tested for its ability to depress phagocytosis and to serve as an immunosuppressant. 
To ascertain the effects of selective impairment of the fixed macrophage compartment on host defense, rabbit anti-rat Kupffer cell serum was raised and tested for its ability to depress phagocytosis and to serve as an immunosuppressant. The ability of the anti-Kupffer cell serum (AKS) to depress intravascular clearance rates of gelatinized RE test lipid emulsion indicated that the antiserum can functionally impair overt phagocytic activity. The phagocytic impairment was manifested by a significantly decreased liver phagocytosis of the lipid emulsion, whereas only a slight decrease in phagocytosis by the spleen was noted. When titered in vitro, AKS was cytotoxic to hepatic and splenic macrophages. Although AKS induced some degree of immunosuppressive activity, it was not as effective as antilymphocytic serum in suppressing the humoral immune response of rats to sheep red blood cells. Selectivity in the cytotoxic activity of AKS was manifested by toxicity for macrophages but no toxicity for thymocytes or splenic lymphocytes. It is suggested that AKS as a specific antimacrophage serum may be useful for assessing the contribution of the reticuloendothelial system to host defense physiology and metabolism.
Although peritoneal (7, 8) and splenic (6) macrophages have been demonstrated to play a major role in immunogenesis, relatively little is known of Kupffer cell involvement in immune phenomena. The recent development of a new method for the isolation of Kupffer cells (18, 19) which exhibit active phagocytosis and metabolism (19) prompted the use of these isolated Kupffer cells to develop an antimacrophage serum to assess the contribution of the hepatic macrophage to immunogenesis.
Antiperitoneal macrophage serum has been employed to ascertain the effects of macrophage removal on humoral or cellular immune responses, or both (1, 3, 11, 13, 14) . Antimacrophage serum impairs the phagocytic event as determined by decreased intravascular clearance rates of colloidal materials (11, 14) , intraperitoneal phagocytosis of foreign red blood cells (3) , and in vitro phagocytosis of a variety of particulate materials (3, 11, 13) . The effects of antimacrophage serum on the immune responses, however, remain a matter of controversy.
Since peritoneal macrophages have been employed as the antigen for the induction of antimacrophage serum (1, 3, 11, 13, 14, 17) , variations in the immunosuppressive activity of the antiperitoneal macrophage serum (1, 3, 14) may be partially explained by the high variability of the harvested peritoneal cellular population used as antigen. The cellular population of peritoneal exudates varies significantly with the time of procurement after intraperitoneal injection of a stimulating irritant (15) and, indeed, whether an irritant is used. Although Hirsch et al. (11) did not employ an irritant before harvesting peritoneal cells, Argyris and Plotkin (1) and Panijel and Cayeux (17) harvested cells 7 days and 10 min, respectively, after stimulation. The immunosuppressive activity of antiperitoneal macrophage serum, reported by some of these investigators (1, 17) , may therefore be related to the number of lymphocytes present in the cellular harvest, i.e., the antilymphocytic activity of antimacrophage serum (14) . Similarly, lack of immunosuppressive activity (3, 14) may be related to the type of phagocytic cell present within the cell harvest fluid, i.e., macrophages which process antigens (7-9, 16) or polymorphonuclear leukocytes which are not effective antigenic processors. Macrophages and leukocytes can be found in various proportions in peritoneal exudate washouts (15) .
Since the Kupffer cells comprise the bulk of the reticuloendothelial system (RES; 2), the ability to immunologically remove these cells from the host defense system should provide a mechanism to define the role that Kupffer cells play in host defense physiology and hepatic function. In addition, it would appear to be advantageous to employ a relatively homogenous macrophage cellular population for the induction of antimacrophage serum.
MATERIALS AND METHODS
Kupffer cells were isolated from the livers of Sprague-Dawley rats by the methods of Pisano et al. (18, 19) . Briefly, minced liver fragments were enzymatically digested with collagenase at 20 C; the resulting isolated Kupifer cells were then trypsinized at 37 C and washed with Hanks balanced salt solution (Difco). The Kupffer cells were suspended in distilled water for 5 sec to remove any red cell contaminants and then resuspended in Hanks balanced salt solution to a final concentration of 107 Kupffer cells/ml.
Anti-Kupifer cell serum (AKS) was raised in rabbits by weekly intraperitoneal injections of 108 Kupffer cells. Seven days after the fourth Kupffer cell injection and every injection thereafter, the rabbits were bled via the marginal ear vein and the serum was titered for a 50% cytotoxicity end point against isolated Kupffer cells by previously described methods (20) . When a cytotoxic titer exceeding 1:20 was obtained, the rabbits were exsanguinated by cardiac puncture and the AKS was heat-inactivated (56 C, 45 min). Rabbit anti-rat red blood cell activity was removed from the antiserum by three isovolumetric adsorptions with packed rat erythrocytes. The antiserum was then frozen at -20 C.
The procedure for preparing rabbit anti-rat lymphocytic serum (ALS; 20) was essentially identical to that described for the preparation of AKS; however, rat thymocytes in Tyrode's solution were employed as antigen. Normal rabbit serum (NRS) was obtained from rabbits which had received weekly intraperitoneal injections of Hanks balanced salt solution. Since ALS induced a depression of hepatic phagocytosis, its cytotoxicity against isolated liver Kupffer cells was also determined (Fig. 1) ( Fig. 1) , it is obvious that ALS manifests significant anti-Kupffer cell activity.
In contrast to the cytotoxicity of ALS towards both macrophages and thymocytes, AKS manifested significant cytotoxicity only towards macrophages (Table 2) . When titered against isolated Kupffer cells, the AKS demonstrated significant cytotoxicity (Table 2 ). In contrast to the titer of AKS against Kupffer cells, AKS never attained 50% killing when titered against rat spleen cells or thymocytes (Table 2) ; however, a definite tendency towards cytotoxic activity was observed when spleen cells were employed as antigen. Slight agglutination was seen when AKS was titered against spleen cells (last dilution to show agglutination, 1:256) and thymocytes (last dilution to show agglutination, 1:512). In contrast, heavy agglutination was still seen at a 1:1,024 dilution when AKS was titered against isolated Kupffer cells. No significant cytotoxicity (titer always <10) or agglutination (last dilution always <1:32) was observed when either Kupffer cells, whole spleen cells, or thymocytes were incubated with NRS.
Since AKS was similar to ALS in reference to its depressive effects upon the RES and cytotoxicity towards isolated Kupffer cells, the ability of AKS to suppress the immune response was compared to ALS-induced immunosuppression (Table 3) . Both the saline-injected and the NRSinjected animals had average titers of 1:319, whereas ALS-recipient animals had an average titer of 1:10. In contrast to control and ALSrecipient groups, rats treated with AKS re-EFFECI OF ANTI-KUPFFER CELL SERUM hemolysin titer of DISCUSSION The impairment in intravascular phagocytosis after AKS administration was equivalent to the impairment induced by the ALS administration. As with ALS, AKS-induced impairment in intravascular clearance was associated with a significant decrease in liver phagocytosis, whereas pulmonary or splenic localization of the lipid emulsion was not altered. The ability of ALS to depress RES activity has been noted by several investigators (10, 14, 20) . Recent studies in our laboratory (20) Although both ALS and AKS manifest similar abilities to impair phagocytosis, the two antisera differed remarkably in their ability to induce an immunosuppression. The administration of ALS essentially obliterated the ability of the recipient to produce hemolysin. In contrast to the results with ALS, AKS induced only a slight reduction in the hemolysin titer.
Although other investigators have reported immunosuppression after the administration of antiperitoneal macrophage sera (1, 14, 17) , it is debatable as to whether antimacrophage sera inhibit humoral antibody formation (1, 14, 17) , cellular immunity, (6) or both. The results reported here appear to indicate that AKS is not a very effective immunosuppressant in regard to humoral antibody formation. However, since it has been shown that humoral antibody immunosuppression by antiperitoneal macrophage serum is dependent on both the dosage of antigen employed and the time of antigen exposure in relation to the period of antiserum administration (1), it is not possible to conclusively state that AKS lacks significant immunosuppressive activity.
In view of the recently developed concept that macrophage processing of antigen is essential to the development of an immune response (7-9, 16), phagocytic impairment should be capable of suppressing the immunocompetency of the organism. Thus, it appears most likely that the AKS lacked immunosuppressive activity in this study because of its selective in vivo action against a population of macrophages, i.e., Kupffer cells which are weak antigen processors (12) , and its possible inability to modify processing macrophages. Anti-Kupffer cell serum provides an immunological means to alter Kupffer cell function, permitting an evaluation of their contribution to metabolic and immune events.
